Scar Treatments for Post-Cesarean Section Pain
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to find the best way to reduce chronic pain from C-section scars. It compares two methods: injecting Lidocaine (a numbing medicine) directly into the scar and using acupuncture needles around the scar as part of the Scar Deactivation Surface Release Technique protocol. The trial also compares these methods with standard physical therapy exercises. Women who are at least three months postpartum and have ongoing pain from a C-section scar might be suitable candidates, especially if they can receive care at Nellis Air Force Base or Scott AFB. As an unphased trial, this study offers a unique opportunity to explore innovative pain relief methods for C-section scars.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that both scar deactivation and lidocaine infiltration are generally well-tolerated for easing pain after a cesarean section.
Scar deactivation involves placing acupuncture needles around the scar and is often used to help with pain. Studies have found it effective in managing pain without major side effects.
Lidocaine infiltration uses lidocaine to numb the area around a cesarean scar, which can reduce pain. Previous studies reported no major side effects, making it a safe option for many patients.
In summary, both treatments are considered safe for managing pain in post-cesarean scars, with no significant safety issues reported in existing studies.12345Why are researchers excited about this trial's treatments?
Researchers are excited about these scar treatment techniques for post-cesarean section pain because they offer innovative approaches compared to standard care like topical creams or surgical scar revisions. The Scar Deactivation Surface Release Technique uses acupuncture needles around the scar, aiming to relieve pain through precise needle placement, which differs from typical direct scar treatments. On the other hand, injecting Lidocaine directly into the scar tissue offers a targeted numbing effect, potentially providing immediate relief without systemic side effects. Lastly, the inclusion of physical therapy using the McKenzie protocol helps address pain by identifying and correcting postural issues, offering a holistic approach that goes beyond conventional pain management.
What evidence suggests that this trial's treatments could be effective for post-cesarean section pain?
In this trial, participants will join different treatment arms to manage post-C-section scar pain. One arm will use the Scar Deactivation Surface Release Technique, which involves acupuncture techniques that previous studies have shown to reduce scar-related pain. Another arm will involve Scar Infiltration with Lidocaine, a local pain reliever, which research supports as effective in significantly lessening pain and reducing the need for additional pain medication. The third arm will involve Physical Therapy, specifically the McKenzie method, which has proven to help reduce pain and improve satisfaction after a C-section. Each of these treatments shows potential in managing post-surgical pain.23678
Are You a Good Fit for This Trial?
This trial is for female DoD beneficiaries, 18 or older, who are experiencing abdominal/back pain starting after a low transverse Cesarean section and are at least 3 months postpartum. They must be able to receive care at specific military bases and not have had certain scar treatments recently.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either scar infiltration with Lidocaine, scar deactivation with acupuncture, or standard physical therapy using the McKenzie Method
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Physical therapy
- Scar Deactivation Surface Release Technique protocol
- Scar Infiltration with 0.25-1% Lidocaine
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jennifer Loomis
Lead Sponsor
Mike O'Callaghan Military Hospital
Collaborator